Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/17/2025

Management of Symptomatic Sinus Tachycardia

Initial Evaluation and Treatment

  • The American College of Cardiology recommends beta blockers as the first-line treatment for symptomatic sinus tachycardia when symptoms correlate with the tachycardia episodes but no significant arrhythmias are present 1
  • Before initiating treatment, evaluate for potential underlying causes of sinus tachycardia, including physiological stressors, medications, endocrine disorders, and other factors 1
  • Beta blockers, such as metoprolol, are recommended as first-line therapy, starting with low doses and titrating based on response 1

Alternative Therapies

  • Non-dihydropyridine calcium channel blockers, such as diltiazem and verapamil, are effective alternatives with fewer respiratory side effects and may be combined with beta blockers in refractory cases 1

Special Considerations

  • Adenosine has minimal to no effect on terminating sinus tachycardia and should be avoided as treatment, although it may be useful diagnostically 2
  • When cardiac function is poor, cardiac output may depend on a rapid heart rate, and "normalizing" the heart rate in compensatory tachycardia can be detrimental 3

Invasive Therapies

  • Sinus node modification by catheter ablation should be considered only in the most refractory cases due to potential complications, including pericarditis, phrenic nerve injury, superior vena cava syndrome, and need for permanent pacing 1